Metoprolol succinate

Alternative Names: Toprol-XL

Metoprolol succinate (extended-release) is a beta-blocker commonly used as a first-line therapy for heart failure with reduced ejection fraction (HFrEF). It works by slowing the heart rate and reducing the heart’s workload, which helps improve heart function over time and reduces the risk of hospitalization and death.

Only the succinate (extended-release) form is approved for CHF—not metoprolol tartrate. It is typically started at a low dose and gradually increased as tolerated. Common side effects include fatigue, bradycardia (slow heart rate), and low blood pressure, especially during dose titration. Despite initial fatigue, long-term use improves symptoms, ejection fraction, and survival in stable CHF patients.

Treatment Type: Prescription Medication

Treatment Class: N/A

Treatment Modality: N/A

Review Summary

0

0 Reviews

Preferred by 0 Reviewers

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
0
1 = Very Expensive 5 = Very Affordable

0

Very Expensive
Relief Speed
0
1 = No Relief 5 = Immediate Relief

0

No Relief
Side Effects
0
1 = Intolerable Effect 5 = No Effect

0

Intolerable Effect
Treatment Line
0
1 = Third-line or more 5 = First-line

0

Third-line or more

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

5
0%
4
0%
3
0%
2
0%
1
0%

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried

No reviews yet.

Be the first to share your experience with this treatment. Your insights help others make informed decisions about their care.